BNP Paribas Financial Markets Portfolio holdings
BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$414M |
| 2 |
State Street Industrial Select Sector SPDR ETF
XLI
|
+$371M |
| 3 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$342M |
| 4 |
Microsoft
MSFT
|
+$339M |
| 5 |
iShares MSCI ACWI ETF
ACWI
|
+$296M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.2B |
| 2 |
Salesforce
CRM
|
+$688M |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$338M |
| 4 |
Eli Lilly
LLY
|
+$239M |
| 5 |
AGN
Allergan plc
AGN
|
+$225M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.68% |
| 2 | Consumer Discretionary | 5.92% |
| 3 | Healthcare | 5.84% |
| 4 | Financials | 5.12% |
| 5 | Communication Services | 5.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ZEUS
3751
DELISTED
Olympic Steel
ZEUS
| $6.42K | ﹤0.01% |
546
-3,139
| -85% | -$31.1K |
|
3752
IDEAYA Biosciences
IDYA
$3.53B
| $6.41K | ﹤0.01% |
+451
| New | +$3.55K |
|
3753
Astrana Health
ASTH
$1.87B
| $6.4K | ﹤0.01% |
388
-2,169
| -85% | -$34.1K |
|
3754
Korea Electric Power
KEP
$14.8B
| $6.37K | ﹤0.01% |
798
+172
| +27% | +$1.49K |
|
3755
Energy Fuels
UUUU
$3.64B
| $6.35K | ﹤0.01% |
4,229
-25,581
| -86% | -$40.7K |
|
|
LUNA
3756
DELISTED
Luna Innovations Incorporated
LUNA
| $6.34K | ﹤0.01% |
+1,085
| New | +$7.07K |
|
|
PFBI
3757
DELISTED
Premier Financial Bancorp
PFBI
| $6.32K | ﹤0.01% |
493
-3,570
| -88% | -$44.2K |
|
3758
PUT
State Street SPDR S&P Bank ETF
KBE
$1.75B
| $6.31K | ﹤0.01% |
2
| – | – |
|
3759
Esquire Financial Holdings
ESQ
$1.59B
| $6.3K | ﹤0.01% |
373
-1,641
| -81% | -$26K |
|
|
FPI
3760
Farmland Partners
FPI
$425M
| $6.3K | ﹤0.01% |
920
-7,716
| -89% | -$50.6K |
|
|
ASPU
3761
DELISTED
ASPEN GROUP, INC.
ASPU
| $6.29K | ﹤0.01% |
+695
| New | +$5.71K |
|
3762
LSI Industries
LYTS
$912M
| $6.27K | ﹤0.01% |
969
+960
| +10,667% | +$5.54K |
|
3763
InfuSystem Holdings
INFU
$249M
| $6.25K | ﹤0.01% |
+542
| New | +$6.23K |
|
3764
Dyadic International
DYAI
$28.1M
| $6.25K | ﹤0.01% |
+722
| New | +$4.8K |
|
|
FLNT
3765
Fluent
FLNT
$132M
| $6.24K | ﹤0.01% |
585
-1,608
| -73% | -$18K |
|
|
ENZ
3766
DELISTED
Enzo Biochem, Inc.
ENZ
| $6.23K | ﹤0.01% |
2,782
-10,812
| -80% | -$27.8K |
|
3767
Veru
VERU
$46M
| $6.2K | ﹤0.01% |
+186
| New | +$6.4K |
|
3768
Comp X International
CIX
$390M
| $6.18K | ﹤0.01% |
447
-123
| -22% | -$1.75K |
|
|
TPCO
3769
DELISTED
Tribune Publishing Company Common Stock
TPCO
| $6.16K | ﹤0.01% |
617
-4,826
| -89% | -$43.3K |
|
|
ARA
3770
DELISTED
American Renal Associates Holdings, Inc
ARA
| $6.12K | ﹤0.01% |
939
-4,812
| -84% | -$31.1K |
|
|
SRT
3771
DELISTED
Startek Inc.
SRT
| $6.11K | ﹤0.01% |
1,202
-3,890
| -76% | -$15.4K |
|
3772
NLI Holdings
NL
$319M
| $6.1K | ﹤0.01% |
1,790
-810
| -31% | -$2.51K |
|
3773
Spero Therapeutics
SPRO
$71.8M
| $6.09K | ﹤0.01% |
450
-3,384
| -88% | -$38K |
|
3774
ProShares Ultra Industrials
UXI
$32.9M
| $6.07K | ﹤0.01% |
+396
| New | +$5.33K |
|
3775
Boston Omaha
BOC
$431M
| $6.06K | ﹤0.01% |
379
-2,915
| -88% | -$48.7K |
|
Similar funds
BNP Paribas Financial Markets's Q2 2020 Portfolio in Review
As of Q2 2020, BNP Paribas Financial Markets held 4,480 positions worth $56.7B, up 16% from $48.8B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
BNP Paribas Financial Markets withdrew a net $2.34B in Q2 2020, closing 174 positions and reducing 2,678 holdings. Its most notable exit was Allergan plc, an estimated $225M position sold in full.
By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 11% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, BNP Paribas Financial Markets opened a new position in State Street SPDR Portfolio Intermediate Term Corporate Bond ETF worth $35.2M.
- BNP Paribas Financial Markets's largest Q2 2020 buy was State Street SPDR Portfolio Intermediate Term Corporate Bond ETF: 962,483 shares worth $35.2M.
- BNP Paribas Financial Markets added most to Apple in Q2 2020, an estimated $414M increase.
- BNP Paribas Financial Markets's biggest Q2 2020 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.2B.
- BNP Paribas Financial Markets fully exited Allergan plc in Q2 2020, selling an estimated $225M.
- BNP Paribas Financial Markets's ten largest holdings make up 20% of its $56.7B portfolio in Q2 2020.
- BNP Paribas Financial Markets opened 164 new positions and closed 174 in Q2 2020.
- BNP Paribas Financial Markets's portfolio value rose 16% quarter-over-quarter to $56.7B.
Based on BNP Paribas Financial Markets's 13F filing for Q2 2020, filed 6 Aug 2020.